Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
basic toxicokinetics
Type of information:
calculation (if not (Q)SAR)
Remarks:
Migrated phrase: estimated by calculation
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Based on toxicityt findings for the substance to be registered and analogues In-vivo testing not justified.

Data source

Reference
Title:
Unnamed
Report date:
2015

Materials and methods

Test guideline
Qualifier:
no guideline followed
Principles of method if other than guideline:
The approach taken is to consider the chemical structure and class of this substance then estimate the endpoints from both the chemistry, including read-across to similar substance types including potential metabolites.

Literature checks were made on the class of substance and there is a lot of data on alkyl amines and their salts. Derivatives of these have been REACH registered and dossiers disseminated.

Test material

Constituent 1
Chemical structure
Reference substance name:
[[(phosphonomethyl)imino]bis[(ethylenenitrilo)bis(methylene)]]tetrakisphosphonic acid, sodium salt
EC Number:
244-751-4
EC Name:
[[(phosphonomethyl)imino]bis[(ethylenenitrilo)bis(methylene)]]tetrakisphosphonic acid, sodium salt
Cas Number:
22042-96-2
Molecular formula:
C9H28N3O15P5.xNa
IUPAC Name:
[[(phosphonomethyl)imino]bis[(ethylenenitrilo)bis(methylene)]]tetrakisphosphonic acid, sodium salt
Radiolabelling:
no

Test animals

Species:
rat

Administration / exposure

Route of administration:
oral: feed

Results and discussion

Main ADME resultsopen allclose all
Type:
absorption
Type:
distribution

Toxicokinetic / pharmacokinetic studies

Details on absorption:
Evidence of absorption from examination of blood and bone parameters in a 90 day dietary study
Details on distribution in tissues:
Effects in blood and bone suggest distribution

Metabolite characterisation studies

Metabolites identified:
no

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information): no bioaccumulation potential based on study results
The substance appears to be absorbed and transported and is not considered accumulative.
Executive summary:

During oral toxicity testing, notably a 90 day dietary study on the penta-phosphonate analogue, there was some evidence of absorption and distribution. There was no suggestion of accumulation, but there is insufficient evidence to indicate whether metabolism or excretion is the main method of elimination.

 

Evidence of distribution is from effects seen in blood parameters and bone data; these changes were considered to be adaptive, although the 90 day dietary study did not include reversibility.

 

The S-9 fraction used for in-vitro mutagenicity studies had little impact on cytotoxicity or other findings.